Search Results - "Castria, Tiago Biachi"

Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case‐control study by Charruf, Amir Zeide, Ramos, Marcus Fernando Kodama Pertille, Pereira, Marina Alessandra, Dias, Andre Roncon, Castria, Tiago Biachi, Zilberstein, Bruno, Cecconelo, Ivan, Ribeiro, Ulysses

“…Background and Objective Neoadjuvant chemotherapy (NACT) followed by radical surgery represents a treatment option for patients with advanced gastric cancer…”
Get full text

Lymph node regression after neoadjuvant chemotherapy: A predictor of survival in gastric cancer by Pereira, Marina Alessandra, Ramos, Marcus Fernando Kodama Pertille, Dias, Andre Roncon, Cardili, Leonardo, Ribeiro, Renan Ribeiro e, Charruf, Amir Zeide, Castria, Tiago Biachi, Zilberstein, Bruno, Ceconello, Ivan, Avancini Ferreira Alves, Venancio, Ribeiro, Ulysses, Mello, Evandro Sobroza

“…Background and Objective Neoadjuvant chemotherapy (nCMT) has been increasingly used in advanced gastric cancer (GC). However, the prognostic impact of tumor…”
Get full text

Cytotoxic T‐lymphocyte‐associated protein 4 in gastric cancer: Prognosis and association with PD‐L1 expression by Pereira, Marina Alessandra, Castria, Tiago Biachi, Ramos, Marcus Fernando Kodama Pertille, Dias, André Roncon, Cardili, Leonardo, Moraes, Rafael Dyer Rodrigues, Zilberstein, Bruno, Nahas, Sergio Carlos, Ribeiro, Ulysses, Mello, Evandro Sobroza

“…Background Cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) is one of the most studied immune checkpoint in gastric cancer (GC). However, the prognostic…”
Get full text

Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and immune microenvironment by Li, Jing, Zhang, Dafang, Liu, Hao, Wang, Danhua, Pan, Chunxiao, Biachi de Castria, Tiago, Mok, Shaffer R S, Zhou, Zegao, Yan, Changqing

“…The family of coiled-coil domain-containing (CCDC) proteins participates in a wide range of physiological functions and plays a pivotal role in governing the…”
Get full text

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza by Queiroz, Marcello Moro, Lima, Jr, Nildevande Firmino, Biachi de Castria, Tiago

“…Biliary tract cancers (BTCs) are a rare pathology and can be divided into four major subgroups: intrahepatic cholangiocarcinoma, extrahepatic…”
Get full text

Predictive factors of recurrence in adenocarcinoma of the esophagogastric junction in the multimodal era by Takeda, Flavio Roberto, Kodama Pertille Ramos, Marcus Fernando, Pereira, Marina Alessandra, Muniz, Renan Rosetti, Tustumi, Francisco, Biachi de Castria, Tiago, Aissar Sallum, Rubens Antonio, Zilberstein, Bruno, Junior, Ulysses Ribeiro, Cecconello, Ivan

“…Adenocarcinoma of the esophagogastric junction (AEGJ) represents a poor prognostic tumor. We evaluated the recurrence pattern and risk factors associated with…”
Get full text

CT Imaging Assessment of Pancreatic Adenocarcinoma Resectability after Neoadjuvant Therapy: Current Status and Perspective on the Use of Radiomics by Khasawneh, Hala, Ferreira Dalla Pria, Hanna Rafaela, Miranda, Joao, Nevin, Rachel, Chhabra, Shalini, Hamdan, Dina, Chakraborty, Jayasree, Biachi de Castria, Tiago, Horvat, Natally

“…Pancreatic adenocarcinoma (PDAC) is the most common pancreatic cancer and is associated with poor prognosis, a high mortality rate, and a substantial number of…”
Get full text

CONVERSION THERAPY FOR GASTRIC CANCER: EXPANDING THE TREATMENT POSSIBILITIES by RAMOS, Marcus Fernando Kodama Pertille, PEREIRA, Marina Alessandra, CHARRUF, Amir Zeide, DIAS, André Roncon, CASTRIA, Tiago Biachi de, BARCHI, Leandro Cardoso, RIBEIRO-JÚNIOR, Ulysses, ZILBERSTEIN, Bruno, CECCONELLO, Ivan

“…ABSTRACT Background: Conversion therapy in gastric cancer (GC) is defined as the use of chemotherapy/radiotherapy followed by surgical resection with curative…”
Get full text

Chemotherapy for advanced non-small cell lung cancer in the elderly population by Santos, Fábio Nasser, Castria, Tiago Biachi de, Cruz, Marcelo Rocha Souza, Riera, Rachel

“…Approximately 50% of patients with newly diagnosed non-small cell lung cancer (NSCLC) are over 70 years of age at diagnosis. Despite this fact, these patients…”
Get full text

What do Cochrane systematic reviews say about the clinical effectiveness of screening and diagnostic tests for cancer? by Bueno, André Tito Pereira, Capelasso, Vladimir Lisboa, Pacheco, Rafael Leite, Latorraca, Carolina de Oliveira Cruz, Castria, Tiago Biachi de, Pachito, Daniela Vianna, Riera, Rachel

“…The purpose of screening tests for cancer is to detect it at an early stage in order to increase the chances of treatment. However, their unrestrained use may…”
Get full text

Return to Intended Oncologic Treatment (RIOT) in Resected Gastric Cancer Patients by Ramos, Marcus Fernando Kodama Pertille, de Castria, Tiago Biachi, Pereira, Marina Alessandra, Dias, Andre Roncon, Antonacio, Fernanda Fronzoni, Zilberstein, Bruno, Hoff, Paulo Marcelo Gehm, Ribeiro, Ulysses, Cecconello, Ivan

“…Background Postoperative chemotherapy (CMT) or chemoradiotherapy (CRT) is commonly recommended for gastric cancer (GC) patients in order to improve survival…”
Get full text

Scoring systems for PD-L1 expression and their prognostic impact in patients with resectable gastric cancer by Pereira, Marina Alessandra, Ramos, Marcus Fernando Kodama Pertille, Dias, André Roncon, Ribeiro, Renan, Cardili, Leonardo, Zilberstein, Bruno, Cecconello, Ivan, Ribeiro, Ulysses, de Mello, Evandro Sobroza, de Castria, Tiago Biachi

“…The combined positive score (CPS) and tumor proportion score (TPS) have been developed to evaluate programmed death ligand-1 (PD-L1) expression, especially due…”
Get full text

Prognostic Impact of Primary Tumor Sidedness in Stage III Colorectal Cancer: Real-World Evidence from a Brazilian Cohort by Protásio, Bruno Medonça, de Castria, Tiago Biachi, Natalino, Renato, Mangone, Flávia R., Saragiotto, Daniel Fernandes, Sabbaga, Jorge, Hoff, Paulo M., Chammas, Roger

“…Primary tumor sidedness (PTS) is an independent prognostic factor in patients with metastatic colorectal cancer (CRC), with a worse prognosis for right-sided…”
Get full text

Remnant gastric cancer: a neglected group with high potential for immunotherapy by Ramos, Marcus Fernando Kodama Pertille, Pereira, Marina Alessandra, de Castria, Tiago Biachi, Ribeiro, Renan Ribeiro e, Cardili, Leonardo, de Mello, Evandro Sobroza, Zilberstein, Bruno, Ribeiro-Júnior, Ulysses, Cecconello, Ivan

“…Purpose The importance of targeted therapy and interest in the study of predictive markers in gastric cancer (GC) have increased in recent years with the use…”
Get full text

SURGICAL TREATMENT IN CLINICAL STAGE IV GASTRIC CANCER: A COMPARISON OF DIFFERENT PROCEDURES AND SURVIVAL OUTCOMES by RAMOS, Marcus Fernando Kodama Pertille, PEREIRA, Marina Alessandra, DIAS, André Roncon, CASTRIA, Tiago Biachi de, SAKAMOTO, Erica, RIBEIRO-JR, Ulysses, ZILBERSTEIN, Bruno, NAHAS, Sérgio Carlos

“…ABSTRACT - BACKGROUND: Even in clinical stage IV gastric cancer (GC), surgical procedures may be required to palliate symptoms or in an attempt to improve…”
Get full text

The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma by Huang, Enmin, Ma, Tao, Zhou, Junyi, Ma, Ning, Yang, Weisheng, Liu, Chuangxiong, Hou, Zehui, Chen, Shuang, de Castria, Tiago Biachi, Zeng, Bing, Zong, Zhen, Zhou, Taicheng

“…The epigenetic regulators of cellular senescence, especially long non-coding RNAs (lncRNAs), remain unclear. The expression levels of lncRNA were previously…”
Get full text

Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer by Maron, Steven B, Chatila, Walid, Walch, Henry, Chou, Joanne F, Ceglia, Nicholas, Ptashkin, Ryan, Do, Richard Kinh Gian, Paroder, Viktoriya, Pandit-Taskar, Neeta, Lewis, Jason S, Biachi De Castria, Tiago, Sabwa, Shalom, Socolow, Fiona, Feder, Lara, Thomas, Jasmine, Schulze, Isabell, Kim, Kwanghee, Elzein, Arijh, Bojilova, Viktoria, Zatzman, Matthew, Bhanot, Umesh, Nagy, Rebecca J, Lee, Jeeyun, Simmons, Marc, Segal, Michal, Ku, Geoffrey Yuyat, Ilson, David H, Capanu, Marinela, Hechtman, Jaclyn F, Merghoub, Taha, Shah, Sohrab, Schultz, Nikolaus, Solit, David B, Janjigian, Yelena Y

“…We report updated clinical outcomes from a phase II study of pembrolizumab, trastuzumab, and chemotherapy (PTC) in metastatic esophagogastric cancer in…”
Get full text

Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials by de Moraes, Francisco Cezar Aquino, Pasqualotto, Eric, Chavez, Matheus Pedrotti, Ferreira, Rafael Oliva Morgado, De Castria, Tiago Biachi, Burbano, Rommel Mario Rodríguez

“…The benefit of adding Zolbetuximab to the treatment in patients with Claudin-18 isoform 2 (CLDN18.2)-positive, human epidermal growth factor receptor…”
Get full text

GASTRIC CANCER WITH POSITIVE EXPRESSION OF ESTROGEN RECEPTOR ALPHA: A CASE SERIES FROM A SINGLE WESTERN CENTER by DA Silva, Alice Cristina Castro, Pereira, Marina Alessandra, Ramos, Marcus Fernando Kodama Pertille, Cardili, Leonardo, Ribeiro, Jr, Ulysses, Zilberstein, Bruno, Mello, Evandro Sobroza de, Castria, Tiago Biachi de

“…Despite advances in therapies, the prognosis of patients with advanced gastric cancer (GC) remains poor. Several studies have demonstrated the expression of…”
Get full text

Identification of a prognostic disulfidptosis-related gene signature in hepatocellular cancer by Zhu, Jinhong, Wu, Yan, Ji, Pengyu, Qi, Jun, Yang, Xuekun, Pocha, Christine, Tustumi, Francisco, Biachi de Castria, Tiago

“…Disulfidptosis regulate various biological processes in cancer. However, there is limited research on the genes related to disulfidptosis in predicting the…”
Get full text